It is a broadly described annual report of Dr. Reddy’s Laboratories Limited in the year of 2004-2005. During the financial year, The Company’s Revenue fell by 3% from Rs. 20,081 million in 2003-04 to Rs. 19,472 million in 2004-05. R&D investments increased by 41% to Rs. 2,803 million (US$ 64 million) Net profit declined from Rs. 2,474 million in 2003-04 to Rs. 211 million as a result of an overall decline in revenue and higher R&D investments. The Company received U.S.$ 22.5 million, of which U.S.$ 2.2 million was recorded as a reduction in the R&D expense line item for the year 2004-05. Net income decreased by 77% from Rs. 2,832 million in 2003-04 to Rs. 655 million in 2004-05.
The Board of Directors of the Company has proposed a dividend of Rs. 5/- on equity shares of Rs. 5/- each. The dividend will be paid on or after 01st August 2005, if approved by the shareholders at the Annual General Meeting scheduled on 27th July 2005.
More Annual Report of Dr. Reddy’s Laboratories Limited:
- Annual Report 2001-2002 of Dr. Reddy’s Laboratories Limited
- Annual Report 2002-2003 of Dr. Reddy’s Laboratories Limited
- Annual Report 2003-2004 of Dr. Reddy’s Laboratories Limited
- Annual Report 2004-2005 of Dr. Reddy’s Laboratories Limited
- Annual Report 2005-2006 of Dr. Reddy’s Laboratories Limited
- Annual Report 2006-2007 of Dr. Reddy’s Laboratories Limited
- Annual Report 2007-2008 of Dr. Reddy’s Laboratories Limited
- Annual Report 2008-2009 of Dr. Reddy’s Laboratories Limited
- Annual Report 2009-2010 of Dr. Reddy’s Laboratories Limited
- Annual Report 2010-2011 of Dr. Reddy’s Laboratories Limited
- Annual Report 2011-2012 of Dr. Reddy’s Laboratories Limited
- Annual Report 2012-2013 of Dr. Reddy’s Laboratories Limited
- Annual Report 2013-2014 of Dr. Reddy’s Laboratories Limited
- Annual Report 2014-2015 of Dr. Reddy’s Laboratories Limited
- Annual Report 2015-2016 of Dr. Reddy’s Laboratories Limited
- Annual Report 2016-2017 of Dr. Reddy’s Laboratories Limited
